Inconsistencies observed in ABCB1 detection by different groups may be due to the use of different detecting probes and antibodies, differences in patient selection (i.e., the stage of the disease and whether the patients had received chemotherapy), and the heterogeneity of ABCB1 expression among tumor cells [4]. The gene discussed is ABCB1; the disease is neoplasm.